Real-Time-PCRAssayforDiagnosisofEntamoebahistolyticaInfection
...lez-Ruiz,A.,R.Haque,A.Aguirre,G.Castanon,A.Hall,F.Guhl,G.Ruiz-Palacios,M.A.Miles,andD.C.Warhurst.1994.ValueofmicroscopyinthediagnosisofdysenteryassociatedwithinvasiveEntamoebahistolytica.J.Clin.Pathol.47:236-239.Haque,R.,I.K.M.Ali,S.Akther,andW.A.Petri,Jr.1998.ComparisonofPCR,isoenzymeanalysis,andan...
醫源資料庫;在線期刊;微生物臨牀雜誌;2005年第43卷第5期GenotypingofMethicillin-ResistantStaphylococcusaureusStrainsfromTwoHospitalsinBangalore,SouthIndia
...geneticmicro-andmacrovariation.J.Clin.Microbiol.42:792-799.Krishnan,P.U.,K.Miles,andN.Shetty.2002.DetectionofmethicillinandmupirocinresistanceinStaphylococcusaureusisolatesusingconventionalandmolecularmethods:adescriptivestudyfromaburnsunitwithhighprevalenceofMRSA.J.Clin.Pathol.55:745-748.McDougal,L...
醫源資料庫;在線期刊;微生物臨牀雜誌;2005年第43卷第7期RedistributionofdistaltubuleNa+-Cl-cotransporter(NCC)inresponsetoahigh-saltdiet
...rats(ketamineim,FortDodgeLaboratories,OverlandPark,KS;xylazine,1:1,vol/vol,Miles,ShawneeMission,KS).UrineandplasmaNa+andK+weremeasuredusingaflamephotometer(RadiometerFLM3,Copenhagen,Denmark).PlasmaaldosteronelevelsweremeasuredinratsfedtheLSorHSdietsfor1wk(n=6each)inplasmacollectedviaheartpunctureaft...
醫源資料庫;在線期刊;美國生理學雜誌;2006年第289卷第8期InternalizationofrenaltypeIIcNa-Picotransporterinresponsetoahigh-phosphatediet
...withPBS,cryoprotectedwith10and20%sucroseat4°C,andembeddedinO.C.T.compound(Miles,Elkart),andfrozeninhexaneat80°C.Frozensections(5μm)werecollectedontosilane-coatedslidesandair-dried.Forimmunofluorescencemicroscopy,serialsectionswereincubatedwithrabbitanti-typeIIa(1:4,000),guineapiganti-typeIIc(1:20...
醫源資料庫;在線期刊;美國生理學雜誌;2005年第288卷第3期PreinfectionSystemicInflammatoryMarkersandRiskofHospitalizationDuetoPneumonia
...pulation.Eligibilitycriteriaincludednoreporteddifficultywithwalkingaquartermile,climbing10steps,orperformingactivitiesofdailyliving.Thosewithrecenttreatmentforcancer,severedementia,orplansofleavingtheareawithin3yrwerealsoexcluded.Theinstitutionalreviewboardsatbothsitesapprovedthestudy.StudyDesignThe...
醫源資料庫;在線期刊;美國呼吸和危急護理醫學;2005年第171卷第12期Ureamayregulateureatransporterproteinabundanceduringosmoticdiuresis
...gaspoturineglucoseat24and48hafterstreptozotocininjection(AmesN-MultistixSG,Miles,Elkhart,IN).Diabeticratswerefedthestandarddietthroughoutthestudy.Anadditionalgroupofratswasmadediabetic,and10%ureawasaddedtothestandardpowdereddiettokeepthepercentageofureaintotalurinarysoluteatthecontrollevel.ToinduceN...
醫源資料庫;在線期刊;美國生理學雜誌;2005年第288卷第1期Anthropometricindicatorsofnutritionalstatus:implicationsforfitness,activity,andhealthinschool-agechildrenandadolescentsfromMaputo,Mozambique
...h,trunklift,curl-up,flexedarmhang,standinglongjump,handgrip,10x5-mrun,and1-milerun.Thesetestsareconsideredmeasuresofflexibility,dynamicmuscularstrengthandendurance,muscularpower,isometricstrength,agility,andcardiovascularendurance.PhysicalactivityPhysicalactivitywasassessedbyaquestionnairedevelopeda...
醫源資料庫;在線期刊;美國臨牀營養學雜誌;2003年77卷第4期Serumleptinconcentrationsandbodyadiposemeasuresinolderblackandwhiteadults
...ersons.Eligibilitycriteriaincludednoreportofanydifficultywalking0.40km(0.25mile),walkingup10steps,orperformingbasicactivitiesofdailyliving.Inaddition,personswhoreportedactivetreatmentforcancerwithinthepast3y,wereplanningtomoveoutoftheareawithin3y,orwereactivelyenrolledinadietorexerciseinterventionst...
醫源資料庫;在線期刊;美國臨牀營養學雜誌;2004年80卷第3期VascularEndothelialGrowthFactor–ExpressingMesenchymalStemCellTransplantationfortheTreatmentofAcuteMyocardialInfarction
...examinationofVEGF,CD31,and-SMactin,theheartembeddedinOCTcompound(TissueTek,Miles,Inc)wasfrozenandcutinto5-μmsections.AntibodiesforhumanVEGF(SantaCruzBiotechnology),CD31(DAKO,Kyoto,Japan),and-smoothmuscleactin(Sigma)wereusedastheprimaryantibody,andthesecondaryantibodywasperoxidaseconjugate(Nichirei,...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2005年第25卷第6期TetradecylselenoaceticAcid,aPPARLigandWithAntioxidant,Antiinflammatory,andHypolipidemicProperties
...pidMeasurementsPlasmalipidsweremeasuredenzymaticallyonaTechniconAxonsystem(Miles).PPARLuciferaseActivityHepG2cellsweretransientlytransfected(0.90µgPPREx3-LUC,0.15µgpcDNA3.1hPPAR//,0.95µgpCMV-5)usingSuperFect(Qiagen),andtreatedwithspecificPPARagonistsorTSAfor24hours.Luciferaseactivi...
醫源資料庫;在線期刊;動脈硬化血栓血管生物學雜誌;2007年第27卷第3期